Simulations Plus Investors
Simulations Plus is a developer of Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET).
Total Funding:
1700000.0
Acquisitions Number:
4
Headquarters:
United States
Funding Status:
IPO
Employee Number:
51-100
Estimated Revenue:
$10M to $50M
Last Funding Type:
Grant
Technology:
Biotechnology, Computer, Data Mining, Enterprise Software, Information Technology, Life Science
Last Funding Date:
2022-03-29
Investors Number:
2.0
Founded Date:
1996-01-01
Industry:
Early Drug Development